Al Wachami Nadia, Guennouni Morad, Iderdar Younes, Boumendil Karima, Arraji Maryem, Mourajid Yassmine, Bouchachi Fatima Zahra, Barkaoui Mohamed, Louerdi Mohamed Lahbib, Hilali Abderraouf, Chahboune Mohamed
Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Hassan First University of Settat, 26000, Settat, Morocco.
Higher School of Education and Training, Chouaîb Doukkali University of El Jadida, El Jadida, Morocco.
BMC Public Health. 2024 Jan 25;24(1):297. doi: 10.1186/s12889-024-17686-9.
Chronic obstructive pulmonary disease (COPD) is a major public health problem. The present study aims to provide a global and regional estimate of the prevalence of COPD based on spirometry according to the two most widely used diagnostic criteria of COPD: fixed ratio (FR) and lower limit of normal (LLN).
We conducted a systematic review of the literature according to PRISMA guidelines. MEDLINE, Web of Sciences, and Scopus databases were searched to identify studies on the spirometry-based prevalence of COPD in individuals aged 40 years and older. The meta-analysis was performed using MedCalc 19 software.
In total, 42 of the 3393 studies reviewed were eligible for inclusion. The overall prevalence of COPD in people aged 40 years and older was 12.64% (95% CI 10.75%-14.65%) and 7.38% (95% CI 5.47% - 9.55%) based on FR and LLN criteria, respectively. By gender, men had a higher prevalence of COPD compared to women (15.47%; 95% CI 12.22%-19.02% for men versus 8.79%; 95% CI 6.94%-10.82% for women). Using the LLN criteria, the prevalence of COPD in both sexes was almost identical (8.67%; 95% CI 8.44%- 8.90% for men and 8.00%; 95% CI 6.42% - 9.73% for women). We reported a high prevalence of COPD among smokers and the elderly by both definitions of airway obstruction. Regional prevalence estimates using the FR definition indicate that the highest COPD prevalence was recorded in the Americas and the lowest was recorded in the Eastern Mediterranean region. Using the LLN definition, the highest prevalence was recorded in the Southeast Asian region and the lowest prevalence was recorded in the American region. The most common COPD stage was stage II, with a prevalence of 50.46%. The results indicate a huge lack of prevalence data in the African and Eastern Mediterranean region. The results were given using a random-effect model due to the high heterogeneity between studies.
Results show that the prevalence of COPD differs according to the diagnostic criteria used. In addition, management and prevention strategies targeting risk factors for COPD are certainly needed to reduce the global burden of this chronic respiratory disease.
慢性阻塞性肺疾病(COPD)是一个重大的公共卫生问题。本研究旨在根据慢性阻塞性肺疾病两种最广泛使用的诊断标准:固定比值(FR)和正常下限(LLN),基于肺活量测定法对慢性阻塞性肺疾病的患病率进行全球和区域估计。
我们根据PRISMA指南对文献进行了系统评价。检索了MEDLINE、科学网和Scopus数据库,以确定关于40岁及以上人群中基于肺活量测定法的慢性阻塞性肺疾病患病率的研究。使用MedCalc 19软件进行荟萃分析。
在3393项纳入评价的研究中,共有42项符合纳入标准。基于FR和LLN标准,40岁及以上人群中慢性阻塞性肺疾病的总体患病率分别为12.64%(95%CI 10.75%-14.65%)和7.38%(95%CI 5.47%-9.55%)。按性别划分,男性慢性阻塞性肺疾病的患病率高于女性(男性为15.47%;95%CI 12.22%-19.02%,女性为8.79%;95%CI 6.94%-10.82%)。采用LLN标准时,男女慢性阻塞性肺疾病的患病率几乎相同(男性为8.67%;95%CI 8.44%-8.90%,女性为8.00%;95%CI 6.42%-9.73%)。根据两种气道阻塞定义,我们报告吸烟者和老年人中慢性阻塞性肺疾病的患病率较高。使用FR定义的区域患病率估计表明,慢性阻塞性肺疾病患病率最高的是美洲,最低的是东地中海地区。使用LLN定义时,患病率最高的是东南亚地区,最低的是美洲地区。最常见的慢性阻塞性肺疾病阶段是II期,患病率为50.46%。结果表明,非洲和东地中海地区严重缺乏患病率数据。由于研究之间存在高度异质性,结果采用随机效应模型给出。
结果表明,慢性阻塞性肺疾病的患病率因所使用的诊断标准而异。此外,肯定需要针对慢性阻塞性肺疾病危险因素的管理和预防策略,以减轻这种慢性呼吸道疾病的全球负担。